Feldkamp C S, McKenna M J
Department of Pathology, Ligand Assay Laboratory, Henry Ford Hospital, Detroit, MI 48202.
Henry Ford Hosp Med J. 1991;39(1):25-9.
Capabilities of new high-sensitivity immunoradiometric assays for thyroid-stimulating hormone (TSH-IRMA) to distinguish among hypothyroid, euthyroid, and hyperthyroid subjects and patient groups with low TSH for nonthyroidal causes suggested an algorithmic approach (directed TSH) to the evaluation of patients with suspected thyroid disease. Utilizing the algorithm, a TSH-IRMA result outside normal limits (0.5 to 5.0 mU/L) generates follow-up tests on the same sample. The interpretation of thyroid function tests (TSH-IRMA, thyroxine, resin uptake, free thyroxine index) and associated studies in the context of different clinical settings is reviewed. The approach is a cost-effective and efficient utilization of laboratory services.
新型高敏免疫放射分析检测促甲状腺激素(TSH-IRMA)区分甲状腺功能减退、甲状腺功能正常和甲状腺功能亢进受试者以及非甲状腺原因导致促甲状腺激素水平低的患者群体的能力,提示了一种用于评估疑似甲状腺疾病患者的算法方法(定向TSH)。利用该算法,TSH-IRMA结果超出正常范围(0.5至5.0 mU/L)会对同一样本进行后续检测。本文回顾了在不同临床环境下甲状腺功能检测(TSH-IRMA、甲状腺素、树脂摄取、游离甲状腺素指数)及相关研究的解读。该方法是对实验室服务的一种经济高效的利用方式。